{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T10:30:00Z","timestamp":1791109800225,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["NO1 MH-90001"],"award-info":[{"award-number":["NO1 MH-90001"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Schizophrenia Research"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.schres.2009.08.016","type":"journal-article","created":{"date-parts":[[2009,9,19]],"date-time":"2009-09-19T05:13:55Z","timestamp":1253337235000},"page":"17-23","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":82,"title":["The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial"],"prefix":"10.1016","volume":"115","author":[{"given":"David L.","family":"Penn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard S.E.","family":"Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piper S.","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana O.","family":"Perkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Losardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Lieberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.schres.2009.08.016_bib1","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0959-4388(00)00202-6","article-title":"The neurobiology of social cognition","volume":"11","author":"Adolphs","year":"2001","journal-title":"Curr. Opin. Neurobiol."},{"key":"10.1016\/j.schres.2009.08.016_bib2","first-page":"27","article-title":"The social brain: a project for integrating primate behavior and neurophysiology in a new domain","volume":"1","author":"Brothers","year":"1990","journal-title":"Concepts Neurosci."},{"key":"10.1016\/j.schres.2009.08.016_bib3","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1093\/schbul\/sbl029","article-title":"The functional significance of social cognition in schizophrenia: a review","volume":"32","author":"Couture","year":"2006","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2009.08.016_bib4","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1093\/oxfordjournals.schbul.a006993","article-title":"Statistical approaches to effectiveness measurement and outcome-driven re-randomizations in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) studies","volume":"29","author":"Davis","year":"2003","journal-title":"Schizophr. Bull."},{"issue":"6","key":"10.1016\/j.schres.2009.08.016_bib5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/S0272-7358(02)00130-7","article-title":"Emotion recognition via facial expression and affective prosody in schizophrenia: a methodological review","volume":"22","author":"Edwards","year":"2002","journal-title":"Clin. Psychol. Rev."},{"key":"10.1016\/j.schres.2009.08.016_bib6","series-title":"Structured Clinical Interview for DSM-IV Axis I Disorders \u2014 Administration booklet","author":"First","year":"1994"},{"issue":"2","key":"10.1016\/j.schres.2009.08.016_bib7","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1176\/appi.ajp.158.2.176","article-title":"Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment","volume":"158","author":"Harvey","year":"2001","journal-title":"Am. J. Psychiatry"},{"issue":"11","key":"10.1016\/j.schres.2009.08.016_bib8","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1176\/ajp.2006.163.11.1918","article-title":"Improvement in social competence with short-term atypical antipsychotic treatment: a randomized, double-blind comparison of quetiapine versus risperidone for social competence, social cognition, and neuropsychological functioning","volume":"163","author":"Harvey","year":"2006","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.schres.2009.08.016_bib9","series-title":"Handbook of Social Functioning in Schizophrenia","first-page":"197","article-title":"Affect perception and social knowledge in schizophrenia","author":"Hellewell","year":"1998"},{"issue":"9","key":"10.1016\/j.schres.2009.08.016_bib10","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1176\/appi.ajp.162.9.1746","article-title":"Effects of antipsychotic treatment on emotion perception deficits in first-episode schizophrenia","volume":"162","author":"Herbener","year":"2005","journal-title":"Am. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.schres.2009.08.016_bib11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/15487760801963652","article-title":"Social cognition training for individuals with schizophrenia: emerging evidence","volume":"11","author":"Horan","year":"2008","journal-title":"Am. J. Psychiatr. Rehabil."},{"issue":"2","key":"10.1016\/j.schres.2009.08.016_bib12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S0920-9964(98)00026-7","article-title":"Risperidone versus haloperidol for perception of emotion in treatment-resistant schizophrenia: preliminary findings","volume":"31","author":"Kee","year":"1998","journal-title":"Schizophr. Res."},{"issue":"2","key":"10.1016\/j.schres.2009.08.016_bib13","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/oxfordjournals.schbul.a033374","article-title":"The effects of atypical antipsychotic drugs on neurocognitive impairment in schizophrenia: a review and meta-analysis","volume":"25","author":"Keefe","year":"1999","journal-title":"Schizophr. Bull."},{"issue":"1","key":"10.1016\/j.schres.2009.08.016_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/oxfordjournals.schbul.a006990","article-title":"Neurocognitive assessment in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) project schizophrenia trial: development, methodology, and rationale","volume":"29","author":"Keefe","year":"2003","journal-title":"Schizophr. Bull."},{"issue":"9","key":"10.1016\/j.schres.2009.08.016_bib15","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1038\/sj.npp.1301072","article-title":"Baseline neurocognitive deficits in the CATIE schizophrenia trial","volume":"31","author":"Keefe","year":"2006","journal-title":"Neuropsychopharmacology"},{"issue":"6","key":"10.1016\/j.schres.2009.08.016_bib16","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/archpsyc.64.6.633","article-title":"Neurocognitive effects of antipsychotic medications in patients with chronic schizophrenia in the CATIE trial","volume":"64","author":"Keefe","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2009.08.016_bib17","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1038\/sj.npp.1301499","article-title":"Efficacy and safety of donepezil in patients with schizophrenia or schizoaffective disorder: significant placebo\/practice effects in a 12-week, randomized, double-blind, placebo-controlled trial","volume":"33","author":"Keefe","year":"2007","journal-title":"Neuropsychopharmacology"},{"issue":"2","key":"10.1016\/j.schres.2009.08.016_bib18","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1037\/0021-843X.102.2.312","article-title":"Emotion perception in schizophrenia: specific deficit or further evidence of generalized poor performance?","volume":"102","author":"Kerr","year":"1993","journal-title":"J. Abnorm. Psychology"},{"issue":"2","key":"10.1016\/j.schres.2009.08.016_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00001504-200403000-00003","article-title":"Recognition of facial emotions in schizophrenia","volume":"17","author":"Kohler","year":"2004","journal-title":"Curr. Opin. Psychiatry"},{"issue":"12","key":"10.1016\/j.schres.2009.08.016_bib20","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","volume":"353","author":"Lieberman","year":"2005","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.schres.2009.08.016_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0920-9964(03)00185-3","article-title":"Improvement in social cognition in patients with schizophrenia associated with treatment with olanzapine","volume":"66","author":"Littrell","year":"2004","journal-title":"Schizophr. Res."},{"issue":"3","key":"10.1016\/j.schres.2009.08.016_bib22","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/oxfordjournals.schbul.a033335","article-title":"Facial expressions of emotions and schizophrenia: a review","volume":"24","author":"Mandal","year":"1998","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2009.08.016_bib23","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.schres.2004.01.009","article-title":"Cognitive functioning, symptoms, and work in supported employment: a review and heuristic model","volume":"70","author":"McGurk","year":"2004","journal-title":"Schizophr. Res."},{"issue":"10","key":"10.1016\/j.schres.2009.08.016_bib24","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1176\/ps.2006.57.10.1421","article-title":"Strategies for coping with cognitive impairments of clients in supported employment","volume":"57","author":"McGurk","year":"2006","journal-title":"Psychiatr. Serv."},{"issue":"4","key":"10.1016\/j.schres.2009.08.016_bib25","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1093\/schbul\/sbi037","article-title":"Cognitive training and supported employment for persons with severe mental illness: one-year results from a randomized controlled trial","volume":"31","author":"McGurk","year":"2005","journal-title":"Schizophr. Bull."},{"issue":"2","key":"10.1016\/j.schres.2009.08.016_bib26","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1176\/appi.ajp.2007.07010042","article-title":"The MATRICS consensus cognitive battery, part 1: test selection, reliability, and validity","volume":"165","author":"Nuechterlein","year":"2008","journal-title":"Am. J. Psychiatry"},{"issue":"2","key":"10.1016\/j.schres.2009.08.016_bib27","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/S0920-9964(00)00005-0","article-title":"Modification of affect perception deficits in schizophrenia","volume":"46","author":"Penn","year":"2000","journal-title":"Schizophr. Res."},{"issue":"1","key":"10.1016\/j.schres.2009.08.016_bib28","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1037\/0033-2909.121.1.114","article-title":"Social cognition in schizophrenia","volume":"121","author":"Penn","year":"1997","journal-title":"Psychol. Bull."},{"key":"10.1016\/j.schres.2009.08.016_bib29","series-title":"Social cognitive impairments. The American Psychiatric Publishing Textbook of Schizophrenia","first-page":"261","author":"Penn","year":"2006"},{"issue":"2","key":"10.1016\/j.schres.2009.08.016_bib30","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.psychres.2005.09.005","article-title":"Neurocognitive and social cognitive predictors of interpersonal skill in schizophrenia","volume":"143","author":"Pinkham","year":"2006","journal-title":"Psychiatry Res."},{"issue":"10","key":"10.1016\/j.schres.2009.08.016_bib31","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1176\/appi.ajp.2007.06091515","article-title":"Cognition and neurocognition: effects of risperidone, olanzapine, and haloperidol","volume":"164","author":"Sergi","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.schres.2009.08.016_bib32","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1017\/S0033291704003356","article-title":"Effectiveness of a two-phase cognitive rehabilitation intervention for severely impaired schizophrenia patients","volume":"35","author":"Silverstein","year":"2005","journal-title":"Psychol. Med."},{"issue":"3","key":"10.1016\/j.schres.2009.08.016_bib33","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1037\/1541-1559.3.3.145","article-title":"Behavioral rehabilitation of the \u2018treatment-refractory\u2019 schizophrenia patient: conceptual foundations, interventions, and outcome data","volume":"3","author":"Silverstein","year":"2006","journal-title":"Psychol. Serv."},{"issue":"1","key":"10.1016\/j.schres.2009.08.016_bib34","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/oxfordjournals.schbul.a006986","article-title":"The National Institute of Mental Health Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Project: schizophrenia trial design and protocol development","volume":"29","author":"Stroup","year":"2003","journal-title":"Schizophr. Bull."},{"issue":"3","key":"10.1016\/j.schres.2009.08.016_bib35","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1176\/ajp.2007.164.3.428","article-title":"Effects of antipsychotic medications on psychosocial functioning in patients with chronic schizophrenia: findings from the NIMH CATIE Study","volume":"164","author":"Swartz","year":"2007","journal-title":"Am. J. Psychiatry"},{"issue":"4","key":"10.1016\/j.schres.2009.08.016_bib36","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1093\/schbul\/sbi038","article-title":"Cognitive remediation and vocational rehabilitation for schizophrenia","volume":"31","author":"Wexler","year":"2005","journal-title":"Schizophr. Bull."},{"issue":"03","key":"10.1016\/j.schres.2009.08.016_bib37","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S146114570500516X","article-title":"A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine, and risperidone in schizophrenia","volume":"8","author":"Woodward","year":"2005","journal-title":"Int. J. Neuropsychopharm."}],"container-title":["Schizophrenia Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996409003946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0920996409003946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T19:22:18Z","timestamp":1760296938000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0920996409003946"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0920996409003946"],"URL":"https:\/\/doi.org\/10.1016\/j.schres.2009.08.016","relation":{},"ISSN":["0920-9964"],"issn-type":[{"value":"0920-9964","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effects of antipsychotic medications on emotion perception in patients with chronic schizophrenia in the CATIE trial","name":"articletitle","label":"Article Title"},{"value":"Schizophrenia Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.schres.2009.08.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}